Wonik Corporation (KOSDAQ:032940)
5,960.00
+160.00 (2.76%)
At close: Jul 16, 2026
Wonik Revenue
Wonik had revenue of 36.96B KRW in the quarter ending March 31, 2026, with 0.99% growth. This brings the company's revenue in the last twelve months to 151.10B, up 6.99% year-over-year. In the year 2025, Wonik had annual revenue of 150.73B with 8.65% growth.
Revenue (ttm)
151.10B
Revenue Growth
+6.99%
P/S Ratio
0.72
Revenue / Employee
1.68B
Employees
90
Market Cap
108.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 150.73B | 12.00B | 8.65% |
| Dec 31, 2024 | 138.74B | 8.86B | 6.82% |
| Dec 31, 2023 | 129.88B | 21.79B | 20.16% |
| Dec 31, 2022 | 108.09B | 13.41B | 14.17% |
| Dec 31, 2021 | 94.67B | 7.18B | 8.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ESTec | 454.02B |
| Woorison F&G | 288.61B |
| Se Gyung Hi Tech | 285.00B |
| TOPTEC | 158.30B |
| HYUNDAI BIOLAND | 135.04B |
| JW Shinyak | 81.04B |
| Cell Biotech | 56.49B |
| Genians | 50.77B |